These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9079642)

  • 21. Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 A.
    Bussiere DE; Kong X; Egan DA; Walter K; Holzman TF; Lindh F; Robins T; Giranda VL
    Acta Crystallogr D Biol Crystallogr; 1998 Nov; 54(Pt 6 Pt 2):1367-76. PubMed ID: 10089498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity in DNA recognition by a peptide from papillomavirus E2 protein.
    Faber-Barata J; Mohana-Borges R; Lima LM
    FEBS Lett; 2006 Apr; 580(8):1919-24. PubMed ID: 16542651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
    Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
    Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
    Bhattacharjee B; Sengupta S
    Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA replication specificity and functional E2 interaction of the E1 proteins of human papillomavirus types 1a and 18 are determined by their carboxyl-terminal halves.
    Gopalakrishnan V; Sheahan L; Khan SA
    Virology; 1999 Apr; 256(2):330-9. PubMed ID: 10191198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
    Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
    Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex.
    Enzenauer C; Mengus G; Lavigne A; Davidson I; Pfister H; May M
    Intervirology; 1998; 41(2-3):80-90. PubMed ID: 9820841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ATP-binding and ATPase activities of human papillomavirus type 16 E1 are significantly weakened by the absence of prolines in its ATP-binding domain.
    Raj K; Stanley MA
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():2949-56. PubMed ID: 8847499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
    Gammoh N; Grm HS; Massimi P; Banks L
    J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
    Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
    J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus.
    Dell G; Wilkinson KW; Tranter R; Parish J; Leo Brady R; Gaston K
    J Mol Biol; 2003 Dec; 334(5):979-91. PubMed ID: 14643661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of sequence-specific, high affinity anti-DNA antibodies.
    Cerutti ML; Centeno JM; Goldbaum FA; de Prat-Gay G
    J Biol Chem; 2001 Apr; 276(16):12769-73. PubMed ID: 11279040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium ions enhance the transfer of human papillomavirus E2 protein from non-specific to specific binding sites.
    Lewis H; Gaston K
    J Mol Biol; 1999 Dec; 294(4):885-96. PubMed ID: 10588894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.
    Newhouse CD; Silverstein SJ
    J Virol; 2001 Feb; 75(4):1722-35. PubMed ID: 11160670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the human papillomavirus type 16 E2 protein identify a region of the protein involved in binding to E1 protein.
    Storey A; Piccini A; Massimi P; Bouvard V; Banks L
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():819-26. PubMed ID: 9049327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of cellular proliferation by the papillomavirus E2 protein.
    Dowhanick JJ; McBride AA; Howley PM
    J Virol; 1995 Dec; 69(12):7791-9. PubMed ID: 7494290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
    Lechner MS; Laimins LA
    J Virol; 1994 Jul; 68(7):4262-73. PubMed ID: 8207801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.
    Ristriani T; Masson M; Nominé Y; Laurent C; Lefevre JF; Weiss E; Travé G
    J Mol Biol; 2000 Mar; 296(5):1189-203. PubMed ID: 10698626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 E2 DNA-binding domain.
    Mok YK; de Prat Gay G; Butler PJ; Bycroft M
    Protein Sci; 1996 Feb; 5(2):310-9. PubMed ID: 8745409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.